Haleos Labs Limited has submitted its annual disclosure to stock exchanges confirming that no promoter shares were encumbered during the financial year 2025-26. The pharmaceutical company, formerly known as SMS Lifesciences India Limited, filed the mandatory disclosure under Regulation 31 of SEBI (SAST) Regulations on April 8, 2026.

Clean Shareholding Structure Maintained

The disclosure, signed by Mr. TVVSN Murthy on behalf of all promoter and promoter group entities, explicitly states that "No shares were encumbered during the financial year 2025-26." This declaration covers all members of the promoter and promoter group, including persons acting in concert, ensuring transparency in shareholding patterns.

Current Promoter Holdings

The company provided a comprehensive breakdown of current shareholding among promoters and promoter group entities:

Regulatory Compliance

The annual disclosure fulfills the company's obligation under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Company Secretary Trupti Ranjan Mohanty submitted the filing to both BSE Limited and National Stock Exchange of India Limited, ensuring proper dissemination to all stakeholders.

Corporate Structure

Haleos Labs Limited, headquartered in Hyderabad, operates from its registered office at Plot No. 19-III, Road No. 71, Jubilee Hills. The company trades on stock exchanges under the symbol HALEOSLABS with scrip code 540679 on BSE. The disclosure reinforces the company's commitment to maintaining transparent corporate governance practices and regulatory compliance in its shareholding structure.

Haleos Labs Limited has submitted its annual confirmation to stock exchanges regarding the continued compliance of reclassified former promoters with SEBI regulations. The company filed the confirmation on April 8, 2026, with both BSE Limited and National Stock Exchange of India Limited.

Reclassification Details

The annual confirmation relates to the reclassification application that was approved by both stock exchanges on April 13, 2022. Under this approval, two former promoters were reclassified from promoter category to public category in accordance with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Former Promoters Status

The confirmation covers two individuals who were reclassified to public category:

Both former promoters currently hold no shares in the company, as indicated by the dash entries in their shareholding status.

Compliance Confirmations

Both Mr. Suresh Babu Potluri and Mr. Hari Kishore Potluri have provided individual declarations dated April 5, 2026, confirming their continued compliance with regulatory requirements. Their confirmations include several key compliance points:

• Do not hold more than 10% of total voting rights in the company
• Do not exercise control over company affairs, directly or indirectly
• Do not have special rights through formal or informal arrangements
• Are not represented on the Board of Directors
• Do not act as key managerial persons of the company
• Are not wilful defaulters as per RBI Guidelines
• Are not fugitive economic offenders
• Have no pending regulatory action against them

Regulatory Framework

The individuals must continue complying with specific sub-clauses of Regulation 31A(3) at all times from the reclassification date. Additionally, they must comply with certain conditions for a period of not less than 3 years from the date of reclassification. Failure to maintain compliance would result in their reclassification as promoters or persons belonging to the promoter group.

Company Information

Haleos Labs Limited, formerly known as SMS Lifesciences India Limited, is headquartered in Hyderabad with its registered office at Plot No. 19-III, Rod No. 71, Jubilee Hills. The company secretary Trupti Ranjan Mohanty signed the filing documents on behalf of the company.